Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$3.12
$3.31
$2.34
$12.03
$7.68M1.2281,367 shs25,226 shs
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.89
$2.83
$1.72
$84.50
$2.89M0.056.33 million shs76,013 shs
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$0.59
$0.62
$0.38
$4.85
$11.08M0.191.75 million shs79,602 shs
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$0.35
$0.27
$0.16
$1.89
$8.98M0.6630.62 million shs751,946 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
0.00%-12.61%-1.27%-3.11%-58.06%
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%-3.02%+30.77%-27.02%-96.54%
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
0.00%+8.34%-10.10%-0.86%-82.95%
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
0.00%-12.96%+83.40%+22.44%-79.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$3.12
$3.31
$2.34
$12.03
$7.68M1.2281,367 shs25,226 shs
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.89
$2.83
$1.72
$84.50
$2.89M0.056.33 million shs76,013 shs
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$0.59
$0.62
$0.38
$4.85
$11.08M0.191.75 million shs79,602 shs
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$0.35
$0.27
$0.16
$1.89
$8.98M0.6630.62 million shs751,946 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
0.00%-12.61%-1.27%-3.11%-58.06%
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%-3.02%+30.77%-27.02%-96.54%
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
0.00%+8.34%-10.10%-0.86%-82.95%
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
0.00%-12.96%+83.40%+22.44%-79.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACON
Aclarion
2.00
Hold$7.50140.38% Upside
Agape ATP Corporation stock logo
ATPC
Agape ATP
1.00
SellN/AN/A
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
1.00
SellN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ATPC, BMGL, BRTX, and ACON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/29/2026
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
DowngradeSell (D-)Sell (E+)
5/29/2026
Aclarion, Inc. stock logo
ACON
Aclarion
Boost Price TargetBuy$7.00 ➝ $7.50
5/27/2026
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
Reiterated RatingSell (E+)
5/22/2026
Aclarion, Inc. stock logo
ACON
Aclarion
UpgradeSell (E)Sell (E+)
5/22/2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
Reiterated RatingSell (E+)
5/8/2026
Aclarion, Inc. stock logo
ACON
Aclarion
DowngradeSell (E+)Sell (E)
5/8/2026
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
UpgradeSell (E+)Sell (D-)
4/24/2026
Aclarion, Inc. stock logo
ACON
Aclarion
UpgradeSell (E)Sell (E+)
4/24/2026
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
DowngradeSell (D-)Sell (E+)
(Data available from 6/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACON
Aclarion
$80K95.94N/AN/A$15.02 per share0.21
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.52M1.90N/AN/A$22.41 per share0.13
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$8.90M1.25N/AN/A$0.20 per share2.95
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$360K24.95N/AN/A$0.04 per share8.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACON
Aclarion
-$7.23M-$9.03N/AN/AN/A-10,320.51%-54.41%-51.71%8/13/2026 (Estimated)
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.28M-$1.33N/AN/AN/A-125.89%-8.43%-7.75%N/A
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
-$9.50MN/AN/AN/AN/AN/AN/AN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$14.24M-$1.07N/AN/AN/A-3,088.27%-508.42%-230.94%8/11/2026 (Estimated)

Latest ATPC, BMGL, BRTX, and ACON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.33N/A-$0.33N/A$0.27 million
5/14/2026Q1 2026
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.20-$0.19+$0.01-$0.12$0.31 million$0.02 million
5/13/2026Q1 2026
Aclarion, Inc. stock logo
ACON
Aclarion
-$1.55-$1.34+$0.21-$1.34$0.03 million$0.02 million
4/13/2026Q4 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.35N/A-$0.35N/A$0.40 million
3/26/2026Q4 2025
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.37-$0.37N/A-$0.32$0.15 million$0.02 million
3/18/2026Q4 2025
Aclarion, Inc. stock logo
ACON
Aclarion
-$3.60-$2.01+$1.59-$2.01$0.02 million$0.02 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/AN/A
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/AN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aclarion, Inc. stock logo
ACON
Aclarion
N/A
19.65
19.65
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
9.01
9.01
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/A
2.35
2.35

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
7.52%
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
69.38%

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
0.01%
Agape ATP Corporation stock logo
ATPC
Agape ATP
2.04%
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
13.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACON
Aclarion
72.46 million2.46 millionNot Optionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
401.00 million981,000Not Optionable
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
3618.79 millionN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
725.48 million22.01 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aclarion stock logo

Aclarion NASDAQ:ACON

$3.12 0.00 (0.00%)
Closing price 06/12/2026 03:59 PM Eastern
Extended Trading
$3.16 +0.04 (+1.28%)
As of 06/12/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$2.89 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$2.88 -0.01 (-0.35%)
As of 06/12/2026 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Basel Medical Group stock logo

Basel Medical Group NASDAQ:BMGL

$0.59 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$0.57 -0.02 (-2.86%)
As of 06/12/2026 06:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Biorestorative Therapies stock logo

Biorestorative Therapies NASDAQ:BRTX

$0.35 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$0.36 +0.01 (+2.13%)
As of 06/12/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.